Diagnostics major Thyrocare Technologies posted a strong performance in the second quarter of FY26, reporting strong growth in both revenue and profit, supported by higher testing volumes across its diagnostic and imaging segments.
The company’s consolidated revenue from operations grew 22% year-on-year (YoY) to Rs 216.5 crore in Q2 FY26 from Rs 177.36 crore in Q2 FY25, as per its filings with the stock exchanges.
Sequentially, the company’s revenue rose 12% from Rs 193 crore in Q1 FY26. The growth was primarily driven by the diagnostic testing…








